SIGLEC15 and hepatocellular carcinoma: Firstly, our global evaluation of HCC transcriptomic data unequivocally reveals that compared with normal tissue, HCC tissue expresses significantly higher inhibitory checkpoint molecules, including CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, TIGIT, and SIGLEC15.